Insider Shareholders with Direct Ownership of Phio Pharmaceuticals Corp. (PHIO)
This section provides a comprehensive overview of the insiders with direct ownership of Phio Pharmaceuticals Corp. (PHIO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Phio Pharmaceuticals Corp. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gerrit Dispersyn
President & CEO |
204,903 | 8,954 | 212,327 $558,420 | 6 |
Mar 01, 2022
Reduced 4.05%
|
|
Robert J Bitterman
Chairman, Pres & CEO |
109,416 | 2,721 | 27,149 $71,401 | 22 |
Jun 10, 2025
Added 6.86%
|
|
H. Paul Dorman
Director |
20,000 | 0 | 20,370 $53,573 | 2 |
Feb 15, 2022
Added 32.93%
|
|
Robert L Ferrara
Director |
46,182 | 0 | 15,666 $41,201 | 10 |
Jun 10, 2025
Added 13.76%
|
|
Robert M. Infarinato
VP, CFO |
11,000 | 0 | 11,000 $28,930 | 2 |
Sep 11, 2024
Added 21.43%
|
|
Caitlin Kontulis
Secretary & VP Finance & Admin |
107,100 | 6,519 | 10,643 $27,991 | 9 |
Mar 01, 2024
Reduced 3.05%
|
|
Patricia A Bradford
Director |
29,500 | 0 | 8,000 $21,040 | 3 |
Sep 11, 2024
Added 50.0%
|
|
Geert Cauwenbergh
Director |
21,500 | 0 | 4,235 $11,138 | 3 |
Feb 17, 2023
Added 26.16%
|
|
Curtis Lockshin
Director |
23,500 | 0 | 2,000 $5,260 | 4 |
Sep 11, 2024
Added 50.0%
|
|
Jonathan E Freeman
Director |
22,500 | 0 | 1,000 $2,630 | 4 |
Sep 11, 2024
Added 50.0%
|